Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Philip Bruggmann"
Filter
Filter
Article category
Publication year
Special Article
Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination
Nathalie Brunner, Philip Bruggmann
J Prev Med Public Health. 2021;54(4):251-258.   Published online June 24, 2021
DOI: https://doi.org/10.3961/jpmph.21.151
  • 12,744 View
  • 152 Download
  • 34 Web of Science
  • 45 Crossref
AbstractAbstract PDF
Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is comparable to the one caused by human immunodeficiency virus or tuberculosis. Today, simple detection methods, highly effective and easy to administer therapies and efficient preventative measures are available to combat hepatitis C. Nevertheless, in most countries around the world, the World Health Organization target of eliminating this infectious disease and its consequences by 2030 are not being met. Significant gaps in care for hepatitis C sufferers still exist, the shortcomings ranging from education and treatment to aftercare. Hepatitis C infection was and still is not on the radar of most politicians and health authorities. National programmes and strategies to combat the disease exist or are being developed in many countries. However, for these to be implemented efficiently and successfully, clear political commitment, strong civil society actors, well-functioning public health structures and the relevant support from global donors are needed.
Summary

Citations

Citations to this article as recorded by  
  • Time to Hepatitis C Care Engagement and Treatment Outcomes in Canadian Immigrants Have Markedly Improved Over Three Decades
    Sabrina Fan, Haris Imsirovic, Gary Garber, Erin Kelly, Curtis Cooper
    Journal of Viral Hepatitis.2026;[Epub]     CrossRef
  • Economic evaluations of the primary prevention programs for viral hepatitis-related liver disease and liver cancer: a systematic literature review
    Milena Lewandowska, Shenghan Cai, Shalini Wijekulasuriya, Putu Novi Arfirsta Dharmayani, Ann Carrigan, Stephen Goodall, Rose Boutros, Jacob George, Amany Zekry, Yvonne Zurynski
    Cost Effectiveness and Resource Allocation.2026;[Epub]     CrossRef
  • SAĞLIK ALANINDA YAPILAN MALİYET ETKİLİLİK ÇALIŞMALARININ SCİENTOMETRİK ANALİZİ
    Gamze Kutlu Örün, Pınar Nur Dalgıç
    Hacettepe Sağlık İdaresi Dergisi.2026; 29(1): 21.     CrossRef
  • Mortality trends of comorbid viral hepatitis C and psychoactive substance use disorders in the United States: Insights from CDC WONDER, 1999–2023
    Masira Fatima, Meraal Faisal, Warda Fatima Shafee, Mahveen Iqbal, Maliha Iqbal, Nawaal Furqan, Muddassir Khalid, Umaima Ali Usmani, Sumia Fatima, Rida Noor
    Medicine.2026; 105(26): e49421.     CrossRef
  • Prediction of ICU length of stay, hospital discharge outcomes and discharge location among ICU-admitted patients diagnosed with viral hepatitis using machine learning: a retrospective cohort study of the MIMIC-IV database
    Dimple Sushma Alluri, Felix M Pabon-Rodriguez
    BMJ Open.2026; 16(6): e106819.     CrossRef
  • Impacts of hepatitis B and C prevention programmes on long-term outcomes of advanced liver disease and hepatocellular carcinoma: A systematic review
    Shenghan Cai, Putu Novi Arfirsta Dharmayani, Milena Lewandowska, Shalini Wijekulasuriya, Gifty Varghese, Ann Carrigan, Maryam Vizheh, Rose Boutros, Stephen Goodall, Jacob George, Amany Zekry, Yvonne Zurynski
    Public Health.2026; 258: 106384.     CrossRef
  • Hepatitis C Treatment Outcomes Among Immigrants: A CANUHC Cohort Analysis
    Haris Imsirovic, Sabrina Fan, Gisela Macphail, Duncan Webster, Daniel Smyth, Sergio Borgia, Jordan J Feld, Sam Lee, Curtis L Cooper
    Open Forum Infectious Diseases.2026;[Epub]     CrossRef
  • Reducing health inequalities for marginalised populations by improving access to hepatitis C virus testing and treatment
    Eugenia Lindile Moyo-Hlahla
    Primary Health Care.2025; 35(4): 22.     CrossRef
  • The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021
    Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, Cheng Han Ng, Nicholas Syn, Benjamin Koh, Ryan Yan Zhe Lim, Karn Wijarnpreecha, Magaret Li Peng Teng, Benjamin Kai Yi Nah, Benedix Kuan Loo Sim, Xianda Cheng, Zixuan Zhang, Kartik Mitra, Toru
    Liver International.2025;[Epub]     CrossRef
  • Integrative immunoinformatics and molecular simulation-based design of a multi-epitope vaccine against hepatitis C virus
    Dharmendrasinh F. Rao, Taral Patel, Saumya K. Patel, Himanshu A. Pandya
    In Silico Research in Biomedicine.2025; 1: 100029.     CrossRef
  • Hepatitis C—Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up
    Sindhuri Benjaram, Shweta Kapur, Anusha McKay, Mohamad Khaled Almujarkesh, Kassandra S. Carter, Alexandra Picardal, Diane Levine, Prateek Lohia
    Journal of Clinical Medicine.2025; 14(13): 4801.     CrossRef
  • The Gut Microbiome in Enteric Viral Infections: Underlying Mechanisms and Therapeutic Approaches
    Alejandro Borrego-Ruiz, Juan J. Borrego
    Microorganisms.2025; 13(10): 2247.     CrossRef
  • Why patients’ knowledge alone isn’t enough: examining behavioral and attitudinal gaps in gestational diabetes management among Chinese women
    Yan Liang, Qingli Liu, Xiaoyun Sun, Yan Wang
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • Chimeric Antigen Receptor Immunotherapy for Infectious Diseases: Current Advances and Future Perspectives
    Maria Kourti, Paschalis Evangelidis, Emmanuel Roilides, Elias Iosifidis
    Pathogens.2025; 14(8): 774.     CrossRef
  • Ascertaining the association between smoking behaviors and viral hepatitis risk: A Mendelian randomization approach
    Birong Lin, Huaxi Ma, Yan Lin, Ting Lin, Xiao Han, Minghua Lin, Haibing Gao
    Tobacco Induced Diseases.2025; 23(July): 1.     CrossRef
  • Antimicrobial stewardship interventions involving community pharmacy teams: a scoping review
    Federico Zerbinato, Scott Cunningham, Antonella Pia Tonna
    JAC-Antimicrobial Resistance.2025;[Epub]     CrossRef
  • Clinical and In vitro Data Shed New Light on the Therapeutic Advantages of Black Seeds (Nigella sativa) for the Treatment of Hepatitis C and Hepatitis B Viral Infections
    Naina Mohamed Pakkir Maideen, Rajkapoor balasubramanian, Kumar Balasubramanian, Mohamed Harsath Jahir Hussain, Mohamed Fahath Shahul Hameed, Rethesh Senthil
    Infectious Disorders - Drug Targets.2025;[Epub]     CrossRef
  • Hepatitis C virus-associated cardiomyopathy: A review of pathogenesis
    Inderjeet Singh Bharaj, Gurkaranvir Singh, Ajit Singh Brar, Aayushi Kacheria, Jasraj Kahlon, Billal Mohmand, Aalam Sohal, Beeletsega T Yeneneh
    World Journal of Virology.2025;[Epub]     CrossRef
  • Seroprevalence and Predictors of Hepatitis B and C Virus Infections Among Patients with Chronic Liver Diseases in Dodoma Region, Tanzania: A Cross-Sectional Study
    Daudi Gyunda, James Yahaya, Emmanuel Sindato, Alfred Meremo
    Hepatic Medicine: Evidence and Research.2025; Volume 17: 125.     CrossRef
  • Opportunities and challenges for the application of artificial intelligence paradigms into the management of endemic viral infections: The example of Chronic Hepatitis C Virus
    Ahmed N. Farrag, Ahmed M. Kamel, Iman A. El‐Baraky
    Reviews in Medical Virology.2024;[Epub]     CrossRef
  • Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit
    Shelley J Walker, Lok B Shrestha, Andrew R Lloyd, Olivia Dawson, Yumi Sheehan, Julia Sheehan, Nonso B C Maduka, Joaquin Cabezas, Matthew J Akiyama, Nadine Kronfli
    International Journal of Drug Policy.2024; 126: 104386.     CrossRef
  • Contemporary Insights into Hepatitis C Virus: A Comprehensive Review
    Malik Sallam, Roaa Khalil
    Microorganisms.2024; 12(6): 1035.     CrossRef
  • A Systematic Literature Review and Meta-Analysis of Primary Evidence Reporting Health-State Preference Values in Chronic Hepatitis B, C, and D
    Ankita Kaushik, Chong Hoon Kim, Sarah Hofmann, Maria João Janeiro, Andrew Lloyd, Filipa Aragão
    Value in Health.2024;[Epub]     CrossRef
  • Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model
    Claire So Jeong Lee, Pedro Mateu-Gelabert, Yesenia Aponte Melendez, Chunki Fong, Shashi N. Kapadia, Melinda Smith, Kristen M. Marks, Benjamin Eckhardt, Jason T. Blackard
    PLOS ONE.2024; 19(8): e0308102.     CrossRef
  • A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs
    Shana Yi, David Truong, Brian Conway
    Journal of Virus Eradication.2024; 10(3): 100388.     CrossRef
  • Prospective approaches to target bovine viral diarrhea virus and hepatitis C virus using miRNA-based inhibitors
    Shazia Tabassum Hakim, Cayatineto HW
    Journal of Human Virology & Retrovirology.2024; 11(1): 36.     CrossRef
  • Metagenomic Detection of Divergent Insect- and Bat-Associated Viruses in Plasma from Two African Individuals Enrolled in Blood-Borne Surveillance
    Gregory S. Orf, Ana Olivo, Barbara Harris, Sonja L. Weiss, Asmeeta Achari, Guixia Yu, Scot Federman, Dora Mbanya, Linda James, Samuel Mampunza, Charles Y. Chiu, Mary A. Rodgers, Gavin A. Cloherty, Michael G. Berg
    Viruses.2023; 15(4): 1022.     CrossRef
  • Gastrointestinal tract and viral pathogens
    Gowthami Sai Kogilathota Jagirdhar, Yashwitha Sai Pulakurthi, Himaja Dutt Chigurupati, Salim Surani
    World Journal of Virology.2023; 12(3): 136.     CrossRef
  • Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016–2021; A multi-centre cross-sectional study
    Yvonne Ayerki Nartey, Rafiq Okine, Atsu Seake-Kwawu, Georgia Ghartey, Yaw Karikari Asamoah, Ampem Darko Jnr Siaw, Kafui Senya, Amoako Duah, Alex Owusu-Ofori, Opei Adarkwa, Seth Agyeman, Sally Afua Bampoh, Lindsey Hiebert, Henry Njuguna, Neil Gupta, John W
    PLOS ONE.2023; 18(6): e0287580.     CrossRef
  • Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis C
    Anna Kleczka, Bogdan Mazur, Krzysztof Tomaszek, Andrzej Gabriel, Radosław Dzik, Agata Kabała-Dzik
    Diagnostics.2023; 13(13): 2187.     CrossRef
  • Rapid and sensitive LAMP/CRISPR-powered diagnostics to detect different hepatitis C virus genotypes using an ITO-based EG-FET biosensing platform
    Hsin-Ying Ho, Wei-Sin Kao, Piyush Deval, Chia-Yen Dai, Yen-Hsu Chen, Ming-Lung Yu, Che-Hsin Lin, Ling-Shan Yu
    Sensors and Actuators B: Chemical.2023; 394: 134278.     CrossRef
  • Hepatitis C and hepatocellular carcinoma in Latin America: Elimination as a path to cancer prevention
    Spencer Goble, Angelo Z. Mattos, Manuel Mendizabal, Jose D. Debes
    Annals of Hepatology.2023; 28(6): 101149.     CrossRef
  • Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey
    Karthik Gnanapandithan, Maged P. Ghali, Yury E. Khudyakov
    PLOS ONE.2023; 18(10): e0293315.     CrossRef
  • The Prevalence of Transfusion-Transmitted Diseases Among Blood Donors in the Central Blood Bank in Makkah, Saudi Arabia
    Mohammad Albshri, Palanisamy Manikandan, Mamdouh Allahyani, Abdulelah Aljuaid, Mazen M Almehmadi, Kamal Alzabeedi, Mohamed Babalgaith, Mosa Alghamdi, Faris Alharbi, Mohammed Alhazmi
    Cureus.2023;[Epub]     CrossRef
  • Assessment of the influence of vitamin D level on the course of chronic hepatitis C in comorbidity with chronic pancreatitis
    M.A. Derbak, O.V. Buchok, T.M. Ganych, O.A. Rishko, V.V. Timashev
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(7): 478.     CrossRef
  • Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
    Ghirmay Ghebrekidan Ghebremeskel, Michael Berhe Solomon, Oliver Okoth Achila, Samuel Tekle Mengistu, Rahel Frezghi Asmelash, Araia Berhane Mesfin, Mohammed Elfatih Hamida
    Scientific Reports.2023;[Epub]     CrossRef
  • DYNAMICS IN MAIN CLINICAL AND IMMUNOLOGICAL INDICATORS IN PATIENTS WITH COMORBIDITY OF CHRONIC HEPATITIS C AND CHRONIC PANCREATITIS FOLLOWING INTEGRATED THERAPY INCLUDING VITAMIN D
    M.A. Derbak, O.V. Buchok, O.O. Boldizhar, O.A. Rishko, M.M. Bletskan
    Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії.2023; 23(4): 84.     CrossRef
  • PECULIARITIES OF THE FUNCTIONAL STATE OF THE LIVER IN PATIENTS WITH CHRONIC HEPATITIS C IN THE PRESENCE OF CHRONIC PANCREATITIS
    Mariya A. Derbak, Olha V. Buchok, Taras M. Ganich, Mariya V. Rivis, Yana V. Lazur, Viktoriya M. Polyak-Tovt, Volodymyr V. Timashev
    Wiadomości Lekarskie.2023; 76(11): 2359.     CrossRef
  • Impact of the direct acting antivirals on chronic hepatitis C prevalence on the Swiss organ transplantation list: a retrospective analysis
    Luis Falcato, Simone Temperli, Philip Bruggmann, Franz Immer
    Exploration of Digestive Diseases.2023; 2(6): 297.     CrossRef
  • ВИВЧЕННЯ ЕФЕКТИВНОСТІ ВІТАМІНУ D В СКЛАДІ КОМПЛЕКСНОЇ ТЕРАПІЇ ХРОНІЧНОГО ГЕПАТИТУ С ПОЄДНАНОГО З ХРОНІЧНИМ ПАНКРЕАТИТОМ
    Ольга Бучок , М. Дербак
    Grail of Science.2023; (34): 360.     CrossRef
  • Impact of the direct acting antivirals on chronic hepatitis C prevalence on the Swiss organ transplantation list: a retrospective analysis
    Luis Falcato, Simone Temperli, Philip Bruggmann, Franz Immer
    Exploration of Digestive Diseases.2023;[Epub]     CrossRef
  • THE EFFECT OF COMPLEX THERAPY INCLUDING VITAMIN D ON THE QUALITY OF LIFE OF PATIENTS WITH CHRONIC HEPATITIS C COMBINED WITH CHRONIC PANCREATITIS
    M. A. Derbak, O. V. Buchok, O. O. Boldizhar, M. M. Bletskan, V. V. Svistak
    Bulletin of Problems Biology and Medicine.2023; 1(2): 166.     CrossRef
  • Intrafamilial transmission risk factors and preventive measures followed by household contacts of hepatitis C patients
    Amala Abdulla Saad Ahmed, Saneya Mohamed Rizk, Nabila Abdel-Kader Abdeldaiem
    Egyptian Nursing Journal.2023; 20(2): 159.     CrossRef
  • Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program
    Paul G. Carty, Conor Teljeur, Cillian F. De Gascun, Paddy Gillespie, Patricia Harrington, Aiden McCormick, Michelle O’Neill, Susan M. Smith, Mairin Ryan
    Value in Health.2022; 25(12): 1947.     CrossRef
  • Oncogenic viruses, cancer biology, and innate immunity
    Maria C White, Xinjun Wu, Blossom Damania
    Current Opinion in Immunology.2022; 78: 102253.     CrossRef

JPMPH : Journal of Preventive Medicine and Public Health
TOP